ZofranLegal.com reports on Zofran lawsuits currently consolidated in a U.S. District Court in Boston, Massachusetts, which now number 204. The suits have been filed against pharmaceutical giant GlaxoSmithKline, and similarly allege that anti-nausea drug Zofran causes birth defects when exposed to developing fetuses.
The surrounding litigation, which started over 9 months ago, has seen a recent surge in public interest. Much discussion has surrounded the upcoming transfer of all Zofran cases to Boston, under MDL number 2657. It is expected that pre-trial proceedings for these cases will begin in the near future.
Zofran is an anti-nausea medication which was approved by the U.S. Food and Drug Administration to treat nausea in cancer patients after chemotherapy or radiation therapy, or to treat nausea in patients who recently underwent anesthesia for surgery. After this approval, however, GSK went on to market the drug as a treatment for morning sickness to OB/Gyns and the general public. This is what is termed “off-label” marketing, and is a large part of allegations within the lawsuits.
The families who are plaintiffs in these cases allege that the mother’s use of Zofran while pregnant subsequently caused their children to develop serious birth defects while in utero. Zofran was never FDA-approved or tested for safety on expectant mothers. The defects most commonly alleged that Zofran has caused in infants are: cleft lip and palate, atrial septal and ventricular septal defect, transposition of the greater vessels, tetralogy of fallot, kidney defects, and clubfoot. Some plaintiffs have infants who have died due to their defects.
Today, there are other families who may still be eligible to join the current Zofran lawsuits. Because of this, the attorneys at Monheit Law are working hard to ensure that individuals involved have the opportunity to explore their full legal rights. Women who were prescribed Zofran while pregnant and who subsequently gave birth to children with defects may be entitled to compensation for medical bills, and pain and suffering. Monheit Law is currently offering these families free legal consultations.
To obtain additional information on Zofran lawsuits, or to ask questions, please contact Attorney Michael Monheit of Monheit Law by calling (877) 620-8411.
Sponsored by an alliance of attorneys, ZofranLegal.com is a resource for parents, families and birth defect survivors interested in learning more about litigation surrounding the nausea drug Zofran and its link to increased risks of major birth defects.
1368 Barrowdale Road, Rydal, PA 19046
April 30, 2016 – Lawsuit Alleges Invokana Side Effects Can Include Diabetic Ketoacidosis, a Life-Threatening Condition Related to Too Much Acid in the Body
April 29, 2016 – Zofran Lawsuit Update: Plaintiffs Question Why GSK Hasn’t Faced Stiffer Penalties
April 27, 2016 – Arkansas Mother Files Zofran Lawsuit Claiming Multiple Defects Caused By Drug
April 25, 2016 – Zofran Lawsuit Plaintiffs Applaud FDA’s Decision Regarding Folic Acid
April 22, 2016 – MyFoxBoston News Release Discusses Concerning Zofran Birth Defect Lawsuits And Drug Safety
April 22, 2016 – Zofran Lawsuit Plaintiffs Note Results Of Japanese Animal Studies Linking Birth Defects To Drug
April 22, 2016 – A Look Back At America’s First Zofran Lawsuit
April 21, 2016 – Significant Increase In Birth Defect Development Investigated By Washington State Amid Mounting Zofran Lawsuits
April 21, 2016 – Zofran Lawsuit Plaintiffs Make Note Of Canadian Label Differences On Drug Which Warn Of Use During Pregnancy
April 20, 2016 – Zofran Lawsuit Plaintiff Claims Infant’s Cleft Palate, Clubfoot, And Respiratory Distress Caused By Drug Exposure
